Recent progress in prion and prion-like protein aggregation

被引:5
|
作者
Yi, Chuan-Wei [1 ]
Xu, Wen-Chang [1 ]
Chen, Jie [1 ]
Liang, Yi [1 ]
机构
[1] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China
基金
中国国家自然科学基金;
关键词
prion protein; prion-like protein; protein misfolding; physiological environment; macromolecular crowding; AMYOTROPHIC-LATERAL-SCLEROSIS; MISFOLDING CYCLIC AMPLIFICATION; MUTANT SUPEROXIDE-DISMUTASE; SPONGIFORM ENCEPHALOPATHY; SCRAPIE PRION; ALZHEIMERS-DISEASE; TAU AGGREGATION; WILD-TYPE; TRANSMISSION; PROPAGATION;
D O I
10.1093/abbs/gmt052
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prion diseases and prion-like protein misfolding diseases involve the accumulation of abnormally aggregated forms of the normal host proteins, such as prion protein and Tau protein. These proteins are special because of their self-duplicating and transmissible characteristics. Such abnormally aggregated proteins mainly formed in neurons, cause the neurons dysfunction, and finally lead to invariably fatal neurodegenerative diseases. Prion diseases appear not only in animals, such as bovine spongiform encephalopathy in cattle and scrapie in sheep, but also in humans, such as CreutzfeldtJacob disease, and even the same prion or prion-like proteins can have many different phenotypes. A lot of biological evidence has suggested that the molecular basis for different strains of prions could be hidden in protein conformations, and the misfolded proteins with conformations different from the normal proteins have been proved to be the main cause for protein aggregation. Crowded physiological environments can be imitated in vitro to study how the misfolding of these proteins leads to the diseases in vivo. In this review, we provide an overview of the existing structural information for prion and prion-like proteins, and discuss the post-translational modifications of prion proteins and the difference between prion and other infectious pathogens. We also discuss what makes a misfolded protein become an infectious agent, and show some examples of prion-like protein aggregation, such as Tau protein aggregation and superoxide dismutase 1 aggregation, as well as some cases of prion-like protein aggregation in crowded physiological environments.
引用
收藏
页码:520 / 526
页数:7
相关论文
共 50 条
  • [1] The Role of Crowded Physiological Environments in Prion and Prion-like Protein Aggregation
    Ma, Qian
    Hu, Ji-Ying
    Chen, Jie
    Liang, Yi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (11): : 21339 - 21352
  • [2] Prion-like protein aggregation of desmin myofibrillar myopathies
    Weihl, C.
    Bieschke, J.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S247 - S248
  • [3] Prion and Prion-like Proteins
    Sano, Kazunori
    Hosokawa, Masato
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2019, 139 (07): : 987 - 987
  • [4] Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
    Sarah K. Kaufman
    Marc I. Diamond
    Neurotherapeutics, 2013, 10 : 371 - 382
  • [5] Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
    Kaufman, Sarah K.
    Diamond, Marc I.
    NEUROTHERAPEUTICS, 2013, 10 (03) : 371 - 382
  • [6] The prion-like effect and prion-like protein targeting strategy in amyotrophic lateral sclerosis
    Yang, Wenzhi
    Liu, Xiangyi
    Fan, Dongsheng
    HELIYON, 2024, 10 (15)
  • [7] Classifying prion and prion-like phenomena
    Harbi, Djamel
    Harrison, Paul M.
    PRION, 2014, 8 (02) : 161 - 165
  • [8] Prion and prion-like diseases in animals
    Aguilar-Calvo, Patricia
    Garcia, Consolacion
    Carlos Espinosa, Juan
    Andreoletti, Olivier
    Maria Torres, Juan
    VIRUS RESEARCH, 2015, 207 : 82 - 93
  • [9] Is Tau a Prion-Like Protein? Preface
    Medina, Miguel
    Avila, Jesus
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 40 : S1 - S3
  • [10] Prion-like behaviour of tau protein
    Goedert, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405